Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The key issues in preventive cardiology.

L Hansson1

  • 1Department of Medicine, University of Göteborg, Ostra Hospital, Sweden.

Blood Pressure. Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000
Same journal

Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL study.

Blood pressure. Supplement·2012
Same journal

Efficacy and safety of valsartan in hypertensive Taiwanese patients: post-marketing surveillance study.

Blood pressure. Supplement·2012
Same journal

Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trial.

Blood pressure. Supplement·2012
Same journal

Post-registration studies for the evaluation of antihypertensive drugs.

Blood pressure. Supplement·2012
Same journal

Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients.

Blood pressure. Supplement·2011
Same journal

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.

Blood pressure. Supplement·2010
See all related articles

Established cardiovascular disease risk factors like hypertension and high cholesterol can be modified for reduced risk. Novel indicators, such as increased left ventricular mass, require further research for intervention strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Risk Factor Analysis

Background:

  • Cardiovascular diseases, including stroke and coronary artery disease, pose significant health risks.
  • Traditional risk factors such as hypertension, smoking, and elevated cholesterol are well-established.
  • Recent research has identified novel risk indicators that may be more potent.

Purpose of the Study:

  • To review established and novel risk factors for cardiovascular disease.
  • To discuss the potential for therapeutic intervention in modifying these risks.
  • To highlight areas for future research in cardiovascular disease prevention.

Main Methods:

  • Review of existing literature on cardiovascular disease risk factors.
  • Analysis of traditional risk factors (hypertension, smoking, cholesterol).

Related Experiment Videos

  • Evaluation of novel risk indicators (left ventricular mass, adipose distribution, insulin sensitivity, lipoproteins).

    • Main Results:

    • Hypertension, smoking, and elevated cholesterol are powerful, modifiable traditional risk factors.
    • Increased left ventricular mass, identified via echocardiography, is a potent novel risk indicator.
    • The impact of interventions on novel risk factors requires further investigation.

    Conclusions:

    • Concerted efforts to reduce established risk factors are crucial for preventive cardiology.
    • Further research is essential to determine the value of interventions targeting novel risk indicators.
    • Novel risk indicators may offer new avenues for cardiovascular disease prevention strategies.